BioNano Genomics (BNGO) Q1 2026 Earnings Report
MX:BNGO Q1 2026 EPS Results
- Actual EPS
- -MXN 14.28
- Consensus EPS
- -MXN 16.54
- Beat/Miss
- Beat by +MXN 2.26
- One Year Ago EPS
- -MXN 21.61
MX:BNGO Q1 2026 Revenue Results
- Actual Revenue
- MXN 125.66M
- Expected Revenue
- MXN 123.43M
- Beat/Miss
- Beat by +MXN 2.24M
- YoY Revenue Growth
- +3.56%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/13/2026
- Time
- After Close
- Conference Call
- Wednesday, May 13, 2026
MX:BNGO Upcoming Earnings
BioNano Genomics's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q1 2026 Earnings Call Audio
MX:BNGO Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:BNGO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -8.46- | -38.34 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -12.59-12.40 | -37.58 | 67.00% (+25.18) | |
| May 13, 2026 | 2026 (Q1) | -16.54-14.28 | -21.61 | 33.91% (+7.33) | |
| Mar 23, 2026 | 2025 (Q4) | -46.51-29.13 | -228.04 | 87.23% (+198.91) | |
| Nov 13, 2025 | 2025 (Q3) | -38.99-38.34 | -586.31 | 93.46% (+547.98) | |
| Aug 14, 2025 | 2025 (Q2) | -49.93-37.58 | -270.61 | 86.11% (+233.02) | |
| May 14, 2025 | 2025 (Q1) | ―- | -676.51 | ― | |
| Mar 31, 2025 | 2024 (Q4) | -56.81-21.61 | -676.51 | 96.81% (+654.90) | |
| Nov 13, 2024 | 2024 (Q3) | -222.70-586.31 | -3630.62 | 83.85% (+3044.31) | |
| Aug 07, 2024 | 2024 (Q2) | -468.26-270.61 | -1398.13 | 80.65% (+1127.52) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
